Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Hematology/Oncology and Stem Cell Therapy
|
October 26, 2012
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival
Henry L Gómez, César Samanéz, Frank Campana, et al.
Veterinary Sciences
|
September 27, 2024
Spermiogram, Kinetics, Flow Cytometric Characteristics and DNA Damage Degree in Boar Ejaculates: Summarization and Clustering
Raquel Ausejo-Marcos, María Teresa Tejedor, Sara Miguel-Jiménez, et al.
Reproduction in Domestic Animals = Zuchthygiene
|
November 12, 2025
Acrosomal Status and PARP-1 Nuclear Markers Could Improve Discrimination of Potential Fertility in Good-Quality Boar Semen Doses
Raquel Ausejo-Marcos, Sara Miguel-Jiménez, M Teresa Tejedor, et al.
The Lancet. Oncology
|
June 2, 2012
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
Ruth Pettengell, Bertrand Coiffier, Geetha Narayanan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 26, 2012
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease
Kevin Harrington, Alain Berrier, Martin Robinson, et al.
Microorganisms
|
September 28, 2024
Efficacy of Indigenous Bacteria in the Biodegradation of Hydrocarbons Isolated from Agricultural Soils in Huamachuco, Peru
Claudio Quiñones-Cerna, Alina Castañeda-Aspajo, Marycielo Tirado-Gutierrez, et al.
The Oncologist
|
July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive marker
Cristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Breast Cancer Research and Treatment
|
May 11, 2010
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
Gabriel N Hortobagyi, Henry L Gomez, Rubi K Li, et al.
Polymers
|
October 28, 2025
Utilization of Hydrolyzed Agro-Industrial Waste from Arti-Chokes to Obtain Structurally Functional Bacterial Cellulose by <i>Komagataeibacter rhaeticus</i> QK23
Claudio Eduardo Quiñones-Cerna, Gabriela Barraza-Jáuregui, José Alfredo Cruz-Monzón, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2007
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
Eva S Thomas, Henry L Gomez, Rubi K Li, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Hematology/Oncology and Stem Cell Therapy
|
October 26, 2012
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival
Henry L Gómez, César Samanéz, Frank Campana, et al.
Veterinary Sciences
|
September 27, 2024
Spermiogram, Kinetics, Flow Cytometric Characteristics and DNA Damage Degree in Boar Ejaculates: Summarization and Clustering
Raquel Ausejo-Marcos, María Teresa Tejedor, Sara Miguel-Jiménez, et al.
Reproduction in Domestic Animals = Zuchthygiene
|
November 12, 2025
Acrosomal Status and PARP-1 Nuclear Markers Could Improve Discrimination of Potential Fertility in Good-Quality Boar Semen Doses
Raquel Ausejo-Marcos, Sara Miguel-Jiménez, M Teresa Tejedor, et al.
The Lancet. Oncology
|
June 2, 2012
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
Ruth Pettengell, Bertrand Coiffier, Geetha Narayanan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 26, 2012
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease
Kevin Harrington, Alain Berrier, Martin Robinson, et al.
Microorganisms
|
September 28, 2024
Efficacy of Indigenous Bacteria in the Biodegradation of Hydrocarbons Isolated from Agricultural Soils in Huamachuco, Peru
Claudio Quiñones-Cerna, Alina Castañeda-Aspajo, Marycielo Tirado-Gutierrez, et al.
The Oncologist
|
July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive marker
Cristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Breast Cancer Research and Treatment
|
May 11, 2010
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
Gabriel N Hortobagyi, Henry L Gomez, Rubi K Li, et al.
Polymers
|
October 28, 2025
Utilization of Hydrolyzed Agro-Industrial Waste from Arti-Chokes to Obtain Structurally Functional Bacterial Cellulose by <i>Komagataeibacter rhaeticus</i> QK23
Claudio Eduardo Quiñones-Cerna, Gabriela Barraza-Jáuregui, José Alfredo Cruz-Monzón, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2007
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
Eva S Thomas, Henry L Gomez, Rubi K Li, et al.
Page
of 2